Alpha DNA Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,019	Closed	-$710K	–	15
2024 Q4	$710K	Buy	+3,019	New	+$710K	0.27%	82
2024 Q2	–	Sell	-5,129	Closed	-$767K	–	201
2024 Q1	$767K	Buy	5,129 +409	+9%	+$61.1K	0.28%	78
2023 Q4	$903K	Buy	+4,720	New	+$903K	0.35%	51